Skip to content

PREDICtors for Quality of Life After Sigmoidectomy for DIVerticular Disease

PREDICtors for Health Related Quality of Life After Elective Sigmoidectomy for DIVerticular Disease: The PREDIC-DIV Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03527706
Acronym
PREDIC-DIV
Enrollment
165
Registered
2018-05-17
Start date
2017-11-28
Completion date
2024-12-31
Last updated
2023-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diverticular Disease of Colon, Quality of Life

Brief summary

To identify predictors for postoperative health related quality of life after elective sigmoidectomy for diverticular disease.

Detailed description

According to current international guidelines, indications for surgical treatment of diverticular disease are inhomogeneous. To date, the measurement of pre- and postoperative quality of life (QoL) is underrepresented. To ensure an individually tailored therapeutical approach, and to avoid unnecessary surgery as well as the risk of a hazardous chronification of the disease, QoL importantly needs to be focused within the decisional process for the best treatment option. The aim of the PREDIC DIV-Study is, to identify predictors for a better postoperative quality of life in patients who undergo elective sigmoidectomy for diverticular disease. PREDIC DIV is a prospective observational study.

Interventions

None listed

Sponsors

Städtisches Klinikum München GmbH
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients, scheduled for elective sigmoidectomy for diverticular disease (Indication: foregoing acute diverticulitis with pericolic or pelvic abscess \>1cm, ongoing complaints after acute uncomplicated diverticulitis, recurrent uncomplicated disease (three or more diverticulitis episodes in combination with the patients wish for surgery), recurrent complicated disease (three or more diverticulitis episodes+complications: stenosis, fistula, chronic pain), urgent wish of patients for surgery after uncomplicated disease. * Age \>18 years * ASA 1-3 * informed consent

Exclusion criteria

* Age \<18 years * ASA 4 * acute diverticulitis with free perforation * acute or forgoing diverticular bleeding * colorectal malignancies (current or foregoing) * immunosuppression (corticoids \> 20 mg prednisolon/d, status post transplant) * advanced malignancy with systemic metastases

Design outcomes

Primary

MeasureTime frameDescription
Postoperative quality of life (QoL) after a follow up of six month: GI-Quality of Life Indexsix monthQuality of life will be assessed by use of the GI-Quality of Life Index

Secondary

MeasureTime frameDescription
Postoperative quality of life (QoL) after a follow up of six month: Visual analogue scale (VAS)six monthQuality of life will be assessed by use of a visual analogue scale (VAS). The scale ranges from 0 to 100 mm. 0 is the least desirable condition. 100 is the most desirable condition.
Quality of life after a follow up of 24 month: SF-3624 monthQuality of life will be assessed by use of SF36-questionnaire
Quality of life after a follow up of 24 month: GI-Quality of Life Index24 monthQuality of life will be assessed by use GI-Quality of Life index-questionnaire
Quality of life after a follow up of 24 month: Visual analogue scale (VAS)24 monthQuality of life will be assessed by use of a visual analogue scale (VAS). The scale ranges from 0 to 100 mm. 0 is the least desirable condition. 100 is the most desirable condition.
Peri- und postoperative morbidity30 days, 6 and 24 monthAssessement by use of Clavien-Dindo-Classification
Mortality30 days, 6 and 24 monthMortality is defined as 30-days postoperative mortality and mortality in association to diverticulitis recurrency
Coexisting characteristics of irritable bowel syndrome (IBS)0, 6 and 24 monthIBS-scoring will be performed pre- and postoperatively by use of ROME IV criteria
Subjective assessment of Diverticulitis severity0, 6 and 24 monthEvaluation of the patients subjective estimate on disease severity by use of a visual analogue scale (VAS). The scale ranges from 0 to 100 mm. 0 is the least desirable condition (=most severe imaginable diverticulitis). 100 is the most desirable condition (=no diverticulitis).
Diverticulitis severity: Classification of Diverticular Disease1 day before surgeryCT-scan based grading of diverticulitis in uncomplicated or complicated disease according to Classification of Diverticular Disease
Diverticulitis severity: Ambrossetti Classification1 day before surgeryCT-scan based grading of diverticulitis in uncomplicated or complicated disease according to Ambrossetti Classification
Diverticulitis severity: Modified Hinchey Classification1 day before surgeryCT-scan based grading of diverticulitis in uncomplicated or complicated disease according to Modified Hinchey Classification
Diverticulitis severity according to preoperative CT-scan1 day before surgeryEvaluation for evidence of pericolic gas
Diverticulitis severity2 days after surgeryhistological grading of inflammation in the resected bowel (Grade 1-4)
Postoperative quality of life (QoL) after a follow up of six month: SF36six monthQuality of life will be assessed by use of the SF36-questionnaire
Postoperative changes in fecal continence0, 6 and 24 monthPre- and postoperative results of Wexner-score
Postoperative changes in urinary continence0, 6 and 24 monthPre- and postoperative results of urinary distress inventory (UDI6)
Postoperative changes in male sexual function0, 6 and 24 monthAssessment of male sexual function by use of International index of erectile function (IIEF)
Postoperative changes in female sexual function0, 6 and 24 monthAssessment of female sexual function by use of Female Sexual Function Index (FSFI)
Preoperative fecal calprotectin1 day preoperativeMeasurement of fecal calprotectin preoperatively
Postoperative fecal calprotectin6 and 24 monthMeasurement of fecal calprotectin postoperatively
Morphological changes of the bowel wall1 day after surgeryAnalysis at the rectosigmoidal junction: overall thickness of the bowel wall
Morphological changes of the bowel wall: thickness of bowel wall1 day after surgeryAnalysis at the the rectosigmoidal junction: thickness of the muscular layer
Morphological changes of the bowel wall: Cells of Cajal1 day after surgeryAnalysis within the inflamed segment: amount of Cajal-cells in the bowel wall
Morphological changes of the bowel wall: Fibrosis1 day after surgeryAnalysis within the inflamed segment: Grade of fibrosis (1-4)
Cost analysisbaseline and 6 and 24 monthReview of disease specific health cost by request at health insurance companies
Productivity analysisbaseline and 6 and 24 monthAssessment of labour productivity by use of the Productivity Cost Questionnaire (iPCQ)
Influence of guideline specific treatment on postoperative quality of life6 and 24 monthPostoperative comparison of indication for surgery with given indications in relevant international Guidelines (German, US, Danish, GB, Italian, Dutch). Review of the association between a guideline-matching treatment and postoperative quality of life. Identification of the guideline, which potentially leads to the best achieved quality of life

Countries

Germany

Contacts

Primary ContactMaximilian Sohn, Dr. med.
maximilian.sohn@klinikum-muenchen.de+49-89-9270702756
Backup ContactFrancesca Di Cerbo, Dr. med.
francesca.cerbo@klinikum-muenchen.de+49-89-92702017

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026